Balyasny Asset Management’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32K Buy
+38,492
New +$35.3K ﹤0.01% 2918
2025
Q4
– Sell
-12,579
Closed -$51.1K – 3187
2025
Q3
$51.1K Buy
+12,579
New +$50.2K ﹤0.01% 2818
2024
Q4
– Sell
-145,909
Closed -$652K – 2855
2024
Q3
$652K Sell
145,909
-197
-0.1% -$924 ﹤0.01% 2150
2024
Q2
$798K Buy
146,106
+130,205
+819% +$820K ﹤0.01% 1877
2024
Q1
$128K Buy
+15,901
New +$141K ﹤0.01% 2476
2023
Q4
– Sell
-43,168
Closed -$345K – 2561
2023
Q3
$345K Buy
+43,168
New +$434K ﹤0.01% 1856

Other funds holding DH

Balyasny Asset Management's DH Position: Q2 2026 in Review

Balyasny Asset Management opened a new position in Definitive Healthcare (DH) in Q2 2026: 38,492 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #2918 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in DH as recently as Q3 2025.

Balyasny Asset Management first reported a position in DH in Q3 2023 and has held it in 6 quarters since. The position peaked at $798K in Q2 2024. 99 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Balyasny Asset Management held 38,492 shares of Definitive Healthcare worth $32K as of Q2 2026.
  • Definitive Healthcare was a new Balyasny Asset Management position in Q2 2026.
  • Definitive Healthcare made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2918 holding.
  • Balyasny Asset Management first reported a position in Definitive Healthcare in Q3 2023 and has held it in 6 quarters since.
  • Balyasny Asset Management's Definitive Healthcare position peaked at $798K in Q2 2024.
  • 99 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.